glp-1 stomach paralysis class action in kentucky Ozempic Lawyer kentucky glp-1 gastroparesis attorney kentucky

Description

While compounded medications aren't FDA-approved, they're regulated by state pharmacy boards and meet USP pharmaceutical standards

These doses are approximately 5.5 and 33 times, respectively, the maximum recommended human dose (MRHD) of 70 mg/day given to adults, on a mg/m2 body surface area basis

Ozempic (semaglutide) Disease area(s): Metabolic diseases Manufacturer(s): Novo Nordisk 2024 Sales (USD): $17.45 billion Why it sold so well: Novo Nordisks GLP-1 blockbuster for type 2 diabetes continued its impressive growth in 2024, with sales increasing by 26% year-over-year to DKK 120.3 billion ($17.45 billion)

"If confirmed in larger studies, these medications could represent a new class of metabolic-based addiction treatments bridging endocrinology and behavioral health." CLICK HERE FOR MORE HEALTH STORIES "Its time to move beyond viewing them as 'weight-loss mania,'" the expert added